2 results
Approved WMOCompleted
To determine the safety and tolerability of L19-IL2 combined with SABR.
Approved WMOCompleted
The aim of the study is to evaluate the efficacy and safety of three IV treatment regimens of sifalimumab in adult subjects with chronic, moderately-to-severely active SLE with an inadequate response to SOC SLE (Standard Of Care treatment for SLE).…